Literature DB >> 30848293

Background paper to the decision to recommend the vaccination with the inactivated herpes zoster subunit vaccine : Statement of the German Standing Committee on Vaccination (STIKO) at the Robert Koch Institute.

A Siedler1, J Koch2, E Garbe3, H Hengel4,5, R von Kries6, T Ledig7, T Mertens8, F Zepp9, K Überla10.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 30848293     DOI： 10.1007/s00103-019-02882-5

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN： 1436-9990            Impact factor:   1.513


× No keyword cloud information.
  8 in total

Review 1.  [Indications for varicella zoster and herpes zoster vaccination in multiple sclerosis: current situation].

Authors:  Alexander Winkelmann; Micha Löbermann; Uwe K Zettl
Journal:  Nervenarzt       Date:  2019-12       Impact factor: 1.214

2.  [Corneal alterations in eyelid diseases].

Authors:  Elisabeth M Messmer
Journal:  Ophthalmologe       Date:  2020-09       Impact factor: 1.059

3.  Burden of Herpes Zoster in Adult Patients with Underlying Conditions: Analysis of German Claims Data, 2007-2018.

Authors:  Manuel Batram; Julian Witte; Magdalena Schwarz; Johannes Hain; Bernhard Ultsch; Maren Steinmann; Amit Bhavsar; Peter Wutzler; Carl-Peter Criée; Christiane Hermann; Klaus Wahle; Martin Füchtenbusch; Wolfgang Greiner
Journal:  Dermatol Ther (Heidelb)       Date:  2021-05-06

4.  Recommendations of the Italian society for infectious and tropical diseases (SIMIT) for adult vaccinations.

Authors:  Massimo Andreoni; Laura Sticchi; Silvia Nozza; Loredana Sarmati; Andrea Gori; Marcello Tavio
Journal:  Hum Vaccin Immunother       Date:  2021-09-15       Impact factor: 4.526

Review 5.  Recombinant zoster vaccine (Shingrix®): a new option for the prevention of herpes zoster and postherpetic neuralgia.

Authors:  Grisuna Singh; Sejin Song; Eunjoo Choi; Pyung-Bok Lee; Francis Sahngun Nahm
Journal:  Korean J Pain       Date:  2020-07-01

6.  Long-term efficacy data for the recombinant zoster vaccine: impact on public health and cost effectiveness in Germany.

Authors:  Desmond Curran; Desirée Van Oorschot; Sean Matthews; Johannes Hain; Ahmed Ehab Salem; Magdalena Schwarz
Journal:  Hum Vaccin Immunother       Date:  2021-12-14       Impact factor: 3.452

Review 7.  Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review.

Authors:  Catherina X Pan; Michelle S Lee; Vinod E Nambudiri
Journal:  Ther Adv Vaccines Immunother       Date:  2022-03-21

Review 8.  Vaccination in Older Adults: An Underutilized Opportunity to Promote Healthy Aging in India.

Authors:  Agam Vora; Alberta Di Pasquale; Shafi Kolhapure; Ashish Agrawal
Journal:  Drugs Aging       Date:  2021-06-14       Impact factor: 3.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.